Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthrax, MEK and cancer.

J F Bodart1, A Chopra, X Liang

  • 1Laboratory of Developmental Cell Biology, Van Andel Research Institute, Grand Rapids, Michigan 49503 USA.

Cell Cycle (Georgetown, Tex.)
|November 14, 2002
PubMed
Summary

Anthrax lethal factor inactivates MEK signaling pathways crucial for cell growth and stress responses. This discovery opens avenues for using anthrax toxin to treat cancers driven by MEK activation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The complete mitochondrial genome of <i>Dunaliella salina</i> CS-265: insights into gene content and phylogenetic placement.

Mitochondrial DNA. Part B, Resources·2026
Same author

Oral health disparities among children with special healthcare needs: a comparative cross-sectional study.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2025
Same author

Arthroscopic Osteochondral Autograft Transplantation (OAT) in Patients with Focal Osteochondral/Chondral Lesions of the Knee Mid-Term Clinical Outcome.

Malaysian orthopaedic journal·2025
Same author

Ratio between biological and targeted synthetic disease-modifying anti-rheumatic drugs and glucocorticoid use in various countries: results from METEOR.

Scandinavian journal of rheumatology·2025
Same author

Epidemiology of antimicrobial resistance in commensal Escherichia coli from healthy dairy cattle on a Mediterranean pasture-based system of Australia: A cross-sectional study.

Journal of dairy science·2024
Same author

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Pathogenesis

Background:

  • Mitogen-activated protein kinase (MEK) kinases regulate cellular responses to mitogens and stress.
  • Aberrant MEK activation is implicated in the development of cancer (tumorigenesis).
  • Anthrax lethal factor (LF), a key component of anthrax toxin, selectively inhibits MEK activity.

Purpose of the Study:

  • To explore the molecular mechanisms of anthrax pathogenesis.
  • To investigate the role of MEK signaling in anthrax.
  • To propose novel therapeutic strategies for cancer using anthrax lethal toxin.

Main Methods:

  • Review of recent advances in understanding anthrax pathogenesis.
  • Analysis of MEK signaling pathways in the context of anthrax infection.
  • Exploration of potential applications of anthrax lethal toxin in oncology.

Main Results:

  • MEK signaling is a critical target in anthrax pathogenesis.
  • Anthrax lethal factor's selective inactivation of MEK provides a unique molecular insight.
  • The study highlights the potential of repurposing anthrax toxin for cancer therapy.

Conclusions:

  • Understanding MEK's role in anthrax pathogenesis is crucial.
  • Anthrax lethal factor's mechanism offers a novel approach for cancer treatment.
  • Targeting MEK signaling with anthrax toxin derivatives could be a promising anti-cancer strategy.

Related Experiment Videos